HTG MOLECULAR DIAGNOSTICS IN's ticker is HTGM and the CUSIP is 40434H104. A total of 29 filers reported holding HTG MOLECULAR DIAGNOSTICS IN in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $536,000 | +12.4% | 1,622,945 | +144.9% | 0.00% | – |
| Q2 2020 | $477,000 | +1544.8% | 662,705 | +1423.5% | 0.00% | – |
| Q3 2019 | $29,000 | -61.3% | 43,500 | +299.1% | 0.00% | – |
| Q1 2017 | $75,000 | -42.3% | 10,900 | -81.3% | 0.00% | – |
| Q4 2016 | $130,000 | +30.0% | 58,200 | +32.3% | 0.00% | – |
| Q3 2016 | $100,000 | +31.6% | 43,994 | +57.0% | 0.00% | – |
| Q2 2016 | $76,000 | – | 28,016 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PERKINS CAPITAL MANAGEMENT INC | 2,426,300 | $802,000 | 0.74% |
| Cowen Prime Services LLC | 1,411,500 | $466,000 | 0.23% |
| GSA CAPITAL PARTNERS LLP | 1,205,873 | $398,000 | 0.07% |
| Nantahala Capital Management | 5,113,958 | $1,690,000 | 0.05% |
| HighMark Wealth Management LLC | 80,000 | $26,000 | 0.02% |
| Kalos Management, Inc. | 72,858 | $24,000 | 0.01% |
| Qube Research & Technologies Ltd | 585,187 | $193,000 | 0.00% |
| WINTON GROUP Ltd | 190,146 | $63,000 | 0.00% |
| Ironwood Financial, llc | 1,571 | $1,000 | 0.00% |
| Virtu Financial LLC | 12,049 | $4,000 | 0.00% |